A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants

Clinical trial NCT05878067 · COMPLETED

Trial details

NCT number: NCT05878067
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Syndrome

Start date: 2023-06-27
Primary completion: 2023-10-06
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.